Enasidenib in IDH-2 mutant AML patients with relapse after allogeneic stem cell transplantation - Vasova, Ingrid; Spörl, Silvia; Guggenberger, Valentin; Berisha, M.; Rech, D.; Behzad, Ali; Brandt, Amelie; Kremer, A.; Mackensen, Andreas; Rösler, Wolf; Winkler, J. (ONCOLOGY RESEARCH AND TREATMENT, 2021)
CRIS-Team WoS Importer:2022-03-25